References
- Azziz R, Carmina E, Chen Z,
Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede
HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers2016;2:16057.
- Jeanes YM, Reeves S. Metabolic consequences of obesity and insulin
resistance in polycystic ovary syndrome: diagnostic and methodological
challenge. Nutr Res Rev 2017;30:97-105.
- Jiao J, Shi B, Wang T, Fang Y, Cao T, Zhou Y, Wang X, Li D.
Characterization of long non-coding RNA and messenger RNA profiles in
follicular fluid from mature and immature ovarian follicles of healthy
women and women with polycystic ovary syndrome. Hum Reprod2018;33:1735-1748.
- Hannou SA, Haslam DE, McKeown NM, Herman MA. Fructose metabolism and
metabolic disease. J Clin Invest 2018;128:545-555.
- Shi B, Feng D, Sagnelli M, Jiao J, Sun X, Wang X, Li D. Fructose
levels are elevated in women with polycystic ovary syndrome with
obesity and hyperinsulinemia. Hum Reprod 2020;35:187-194.
- Russo E, Leoncini G, Esposito P, Garibotto G, Pontremoli R, Viazzi F.
Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk
Starting at Pediatric Age. Int J Mol Sci 2020;21:4479.
- Lanaspa MA, Tapia E, Soto V, Sautin Y, Sánchez-Lozada LG. Uric Acid
and Fructose: Potential Biological Mechanisms. Semin Nephrol2011;31:426-432.
- Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG,
Feig DI, Shafiu M, Segal M, Glassock RJ, Shimada M, Roncal C, Nakagawa
T. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause
Type 2 Diabetes? Endocr Rev 2009;30:96-116.
- Mumford SL, Dasharathy SS, Pollack AZ, Perkins NJ, Mattison DR, Cole
SR, Wactawski-Wende J, Schisterman EF. Serum uric acid in relation to
endogenous reproductive hormones during the menstrual cycle: findings
from the BioCycle study. Hum Reprod 2013;28:1853-1862.
- Orio F, Palomba S. Reproductive endocrinology: New guidelines for the
diagnosis and treatment of PCOS. Nat Rev Endocrinol 2014;10:130-132.
- Li D, Liu HX, Fang YY, Huo JN, Wu QJ, Wang TR, Zhou YM, Wang XX, Ma
XX. Hyperhomocysteinemia in polycystic ovary syndrome: decreased
betaine-homocysteine methyltransferase and cystathionine
beta-synthase-mediated homocysteine metabolism. Reprod Biomed
Online 2018;37:234-241.
- Flegal KM. Body-Mass Index and All-Cause Mortality. Lancet2017;389:2284-2285.
- World Health Organization (WHO) International Obesity Task Force. The
Asia-Pacific perspective: redefining obesity and its treatment. WHO
Western Pacific Region, Geneva, Switzerland: World Health
Organization, 2000.
- Friedrich N, Thuesen B, Jørgensen T, Juul A, Spielhagen C,
Wallaschofksi H, Linneberg A. The association between IGF-I and
insulin resistance: a general population study in Danish adults.Diabetes Care 2012;35:768-773.
- Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med2017;167:ITC81-ITC96.
- Na Z, Jiang H, Meng Y, Song J, Feng D, Fang Y, Shi B, Li D.
Association of galactose and insulin resistance in polycystic ovary
syndrome: A case-control study. EClinicalMedicine2022;47:101379.
- Stone C, Koo CY. Additive splines in statistics. In Proceedings of the
Statistical Computing Section ASA. Washington, DC, American
Statistical Association, 1985.
- Salazar MC, Rosen JE, Wang Z, Arnold BN, Thomas DC, Herbst RS, Kim AW,
Detterbeck FC, Blasberg JD, Boffa DJ. Association of Delayed Adjuvant
Chemotherapy With Survival After Lung Cancer Surgery. JAMA
Oncol 2017;3:610-619.
- Desquilbet L, Mariotti F. Dose-response analyses using restricted
cubic spline functions in public health research. Stat Med2010;29:1037-1057.
- Tan Q, Lv Y, Zhao F, Zhou J, Yang Y, Liu Y, Zhang M, Lu F, Wei Y, Chen
X et al. Association of low blood arsenic exposure with level of
malondialdehyde among Chinese adults aged 65 and older. Sci
Total Environ 2021;758:143638.
- de Medeiros SF, Yamamoto MMW,
Souto de Medeiros MA, Barbosa BB, Soares JM, Baracat EC. Changes in
clinical and biochemical characteristics of polycystic ovary syndrome
with advancing age. Endocr Connect 2020;9:74-89.
- Taskinen MR, Packard CJ, Borén J. Dietary Fructose and the Metabolic
Syndrome. Nutrients 2019;11:1987.
- Caliceti C, Calabria D, Roda A, Cicero AFG. Fructose Intake, Serum
Uric Acid, and Cardiometabolic Disorders: A Critical Review.Nutrients 2017;9:395.
- Emmerson BT. Effect of oral fructose on urate production. Ann
Rheum Dis 1974;33:276-280.
- Chang YH, Chiang YF, Chen HY, Huang YJ, Wang KL, Hong YH, Ali M, Shieh
TM, Hsia SM. Anti-Inflammatory and Anti-Hyperuricemic Effects of
Chrysin on a High Fructose Corn Syrup-Induced Hyperuricemia Rat Model
via the Amelioration of Urate Transporters and Inhibition of NLRP3
Inflammasome Signaling Pathway. Antioxidants (Basel)2021;10:564.
- Tappy L, Lê KA. Metabolic effects of fructose and the worldwide
increase in obesity. Physiol Rev 2010;90:23-46.
- Hu J, Xu W, Yang H, Mu L. Uric acid participating in female
reproductive disorders: a review. Reprod Biol Endocrinol2021;19:65.
- Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of
glucose and lipid metabolism. Biochimie 2015;116:17-23.
- Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis:
fructose-induced hyperuricemia as a causal mechanism for the epidemic
of the metabolic syndrome. Nat Clin Pract Nephrol 2005;1:80-86.
- Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, He H, Liu X, Li Y, Yu C. Uric
acid regulates hepatic steatosis and insulin resistance through the
NLRP3 inflammasome-dependent mechanism. J Hepatol2016;64:925-932.